Firibastat (QGC001) Period 1
QGC001-3QG2
Phase 3 small_molecule terminated
Quick answer
Firibastat (QGC001) Period 1 for Hypertension (HTN) is a Phase 3 program (small_molecule) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Quantum Biopharma
- Indication
- Hypertension (HTN)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated